Literature DB >> 7283423

Effect of mixing on rifampin bactericidal activity against staphylococci.

S H Zinner, M Husson, J Klastersky.   

Abstract

Minimal bactericidal concentrations of rifampin were significantly increased, and serum bactericidal activity from volunteers receiving this drug was significantly decreased by vigorous mixing of microtiter plates before sampling when tested against Staphylococcus aureus and Staphylococcus epidermidis at 10(5) and 10(6) colony-forming units per ml. These results suggest that microtiter estimates of the bactericidal activity of rifampin against staphylococci should be performed after vigorous shaking.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7283423      PMCID: PMC181678          DOI: 10.1128/AAC.20.2.267

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.

Authors:  R J Faville; D E Zaske; E L Kaplan; K Crossley; L D Sabath; P G Quie
Journal:  JAMA       Date:  1978-10-27       Impact factor: 56.272

2.  Comparison of the antibacterial activity of rifampicin and other antibiotics.

Authors:  W R McCabe; V Lorian
Journal:  Am J Med Sci       Date:  1968-10       Impact factor: 2.378

3.  Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections.

Authors:  J Klastersky; D Daneau; G Swings; D Weerts
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Application of microtitration techniques to bacteriostatic and bactericidal antibiotic susceptibility testing.

Authors:  H J Harwick; P Weiss; F R Fekety
Journal:  J Lab Clin Med       Date:  1968-09

5.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

6.  Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

7.  Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices.

Authors:  G L Archer; M J Tenenbaum; H B Haywood
Journal:  JAMA       Date:  1978-08-25       Impact factor: 56.272

8.  In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

Authors:  C U Tuazon; M Y Lin; J N Sheagren
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

9.  Synergistic activity of trimethoprim and amikacin against gram-negative bacilli.

Authors:  T L Parsley; R B Provonchee; C Glicksman; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

10.  The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.

Authors:  R M Massanari; S T Donta
Journal:  Chest       Date:  1978-03       Impact factor: 9.410

  10 in total
  5 in total

1.  Influence of technical factor variations on serum inhibition and bactericidal titers.

Authors:  B F Woolfrey; R T Lally; K R Tait
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

2.  Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

3.  In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.

Authors:  M Maduri Traczewski; D A Goldmann; P Murphy
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

4.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

5.  In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study.

Authors:  Christian Garzoni; Ilker Uçkay; Wilson Belaieff; Dominique Breilh; Domizio Suvà; Elzbieta Huggler; Daniel Lew; Pierre Hoffmeyer; Louis Bernard
Journal:  Springerplus       Date:  2014-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.